DNA
Price
$8.27
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
12 days until earnings call
IMUX
Price
$1.34
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
9 days until earnings call
Ad is loading...

DNA vs IMUX

Header iconDNA vs IMUX Comparison
Open Charts DNA vs IMUXBanner chart's image
Ginkgo Bioworks Holdings
Price$8.27
Change-$0.00 (-0.00%)
Volume$577.15K
CapitalizationN/A
Immunic
Price$1.34
Change-$0.00 (-0.00%)
Volume$891.41K
CapitalizationN/A
View a ticker or compare two or three
DNA vs IMUX Comparison Chart
Loading...
DNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
IMUX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
DNA vs. IMUX commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNA is a Buy and IMUX is a Buy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (DNA: $8.27 vs. IMUX: $1.35)
Brand notoriety: DNA and IMUX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNA: 41% vs. IMUX: 116%
Market capitalization -- DNA: $452.94M vs. IMUX: $148.63M
DNA [@Biotechnology] is valued at $452.94M. IMUX’s [@Biotechnology] market capitalization is $148.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNA’s FA Score shows that 1 FA rating(s) are green whileIMUX’s FA Score has 0 green FA rating(s).

  • DNA’s FA Score: 1 green, 4 red.
  • IMUX’s FA Score: 0 green, 5 red.
According to our system of comparison, both DNA and IMUX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNA’s TA Score shows that 6 TA indicator(s) are bullish while IMUX’s TA Score has 3 bullish TA indicator(s).

  • DNA’s TA Score: 6 bullish, 3 bearish.
  • IMUX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, DNA is a better buy in the short-term than IMUX.

Price Growth

DNA (@Biotechnology) experienced а -7.29% price change this week, while IMUX (@Biotechnology) price change was -12.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

DNA is expected to report earnings on Nov 11, 2024.

IMUX is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNA($453M) has a higher market cap than IMUX($149M). IMUX YTD gains are higher at: -10.000 vs. DNA (-87.766). IMUX has higher annual earnings (EBITDA): -93.53M vs. DNA (-763.83M). DNA has more cash in the bank: 730M vs. IMUX (79.7M). IMUX has less debt than DNA: IMUX (955K) vs DNA (452M). DNA has higher revenues than IMUX: DNA (184M) vs IMUX (0).
DNAIMUXDNA / IMUX
Capitalization453M149M304%
EBITDA-763.83M-93.53M817%
Gain YTD-87.766-10.000878%
P/E RatioN/AN/A-
Revenue184M0-
Total Cash730M79.7M916%
Total Debt452M955K47,330%
FUNDAMENTALS RATINGS
IMUX: Fundamental Ratings
IMUX
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNAIMUX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 13 days ago
85%
Declines
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 20 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
DNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
IMUX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

IMUX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMUX has been loosely correlated with NTLA. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if IMUX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMUX
1D Price
Change %
IMUX100%
-2.88%
NTLA - IMUX
41%
Loosely correlated
+2.45%
RVMD - IMUX
40%
Loosely correlated
+2.87%
DNA - IMUX
40%
Loosely correlated
+1.35%
ALEC - IMUX
39%
Loosely correlated
+6.91%
PGEN - IMUX
38%
Loosely correlated
-0.61%
More